This biotech innovator in cystic fibrosis therapies reported a notable insider sale, as disclosed in recent SEC filings.
In reality, the tech sector really isn't any more expensive than the broader market. Given projected earnings growth rates in ...
Adaptive Biotechnologies, a leader in immune-driven diagnostics, reported a notable insider sale amid strong one-year stock ...
At the start of the year, it looked as though the price of gold was only going in one direction: up. It rose to more than ...
This specialty pharma firm focused on pain management therapies reported a notable insider sale amid steady revenue and ...
There are currently 11 companies with market caps of $1 trillion or more, but only three are members of the distinguished $3 ...
Both tech giants have suffered in the recent market pullback, but one presents a more compelling artificial intelligence growth story today.
Business has been booming for data analytics company Palantir Technologies ( PLTR 3.85%) in recent years. Its artificial ...
Today, March 30, 2026, investors are weighing EV price cuts against an ambitious AI and robotaxi pivot shaping this market ...
If you're looking for a way to reduce some of your risk in the stock market today, a good exchange-traded fund (ETF) to ...
Fermi’s widening losses, tenant delays, and new financing are redefining the AI data-center risk profile, today, March 30, ...
The comparison to the dot-com mania of the late 1990s, which came to a screeching halt in the early 2000s, is understandable, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results